Profile data is unavailable for this security.
About the company
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
- Revenue in CAD (TTM)53.38m
- Net income in CAD-32.12m
- Incorporated2003
- Employees70.00
- LocationValeo Pharma Inc16667 Hymus BlvdKIRKLAND H9H 4R9CanadaCAN
- Phone+1 (514) 693-8832
- Fax+1 (514) 693-8832
- Websitehttps://valeopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eve & Co Inc | 7.77m | -5.92m | 3.74m | -- | -- | -- | -- | 0.4812 | -0.2055 | -0.2055 | 0.2698 | 0.733 | 0.1519 | 0.7493 | 8.73 | -- | -11.58 | -- | -24.24 | -- | -3.10 | -- | -76.22 | -- | 0.062 | -5.05 | 0.4892 | -- | 2.94 | -- | -71.97 | -- | -- | -- |
Valeo Pharma Inc | 53.38m | -32.12m | 6.41m | 70.00 | -- | -- | -- | 0.1202 | -0.3412 | -0.3412 | 0.5669 | -0.6388 | 1.37 | 5.00 | 11.08 | 427,016.00 | -82.64 | -64.35 | -- | -113.22 | 16.51 | 23.88 | -60.18 | -69.71 | 0.202 | -1.16 | 9.94 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
Voyageur Pharmaceuticals Ltd | 0.00 | -1.30m | 7.67m | -- | -- | 6.12 | -- | -- | -0.0096 | -0.0096 | 0.00 | 0.009 | 0.00 | -- | -- | -- | -57.04 | -74.47 | -82.81 | -120.92 | -- | -- | -- | -- | 0.1615 | -279.30 | 0.0311 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
Khiron Life Sciences Corp | 16.14m | -30.66m | 9.31m | 310.00 | -- | -- | -- | 0.5769 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Valeo Pharma Inc's reporting currency: Canadian Dollar CAD